Looking forward to #ASH2019 in less than two weeks! Read the thread below for a list of 10 abstracts that I think offer new practice-changing insights, particularly for community oncologists . #leusm#mmsm
(1/10) Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Overall Survival in Alcyone
Abstract: ash.confex.com/ash/2019/webpr…